Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
暂无分享,去创建一个
A. Cutillo | R. Kanner | A. Renzetti | R. Menlove | S. Watanabe | A. Renzetti | R. Bachand | M. Szalkowski | Romeo T. Bachand
[1] C. Rizzi. Statistical Methods , 2020, Springer Theses.
[2] C. Mélot,et al. Enhancement of hypoxic pulmonary vasoconstriction by low dose almitrine bismesylate in normal humans. , 1989, The American review of respiratory disease.
[3] W. MacNee,et al. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. , 1986, The American review of respiratory disease.
[4] W. Johanson,et al. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. , 1986, Annals of internal medicine.
[5] A. Harf,et al. Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction. , 1986, Chest.
[6] J. West,et al. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog. , 2015, The American review of respiratory disease.
[7] S. Pugsley,et al. The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction. , 1983, The American review of respiratory disease.
[8] C. Mélot,et al. Improvement in ventilation-perfusion matching by almitrine in COPD. , 1983, Chest.
[9] M. Paiva,et al. Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD. , 1983, European journal of respiratory diseases. Supplement.
[10] J. Stradling,et al. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease. , 1983, European journal of respiratory diseases. Supplement.
[11] J. Charpin,et al. Long term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study. , 1983, European journal of respiratory diseases. Supplement.
[12] P. Clayton,et al. Lung volumes in healthy nonsmoking adults. , 1982, Bulletin europeen de physiopathologie respiratoire.
[13] R M Gardner,et al. Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.
[14] A. Baune,et al. Trace determination of almitrine in plasma by gas-liquid chromatography using a nitrogen-phosphorus detector. , 1981, Journal of chromatography.
[15] C. Mélot,et al. Effects of almitrine in decompensated chronic respiratory insufficiency. , 1981, Bulletin europeen de physiopathologie respiratoire.
[16] C. Mélot,et al. Dissociation entre ventilation et gaz du sang sous perfusion d'almitrine chez des patients porteurs de bronchopneumopathie chronique obstructive(B.P.C.O.) , 1980 .
[17] R. Kirk. Experimental Design: Procedures for the Behavioral Sciences , 1970 .
[18] J. E. Cohn,et al. Modified body plethysmograph for study of cardiopulmonary physiology. , 1961, Journal of applied physiology.
[19] J. H. Comroe,et al. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. , 1956, The Journal of clinical investigation.